You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 24 No. 4, April 1971 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Urinary Cyclic AMP Excretion in Depression and Mania

Effects of Levodopa and Lithium Carbonate

Michael I. Paul, MD; Hinrich Cramer, MD; Frederick K. Goodwin, MD

Arch Gen Psychiatry. 1971;24(4):327-333.


Abstract

The 24 hour urinary excretion of adenosine 3',5'-cyclic monophosphate (cyclic AMP) was studied in a series of 40 patients with affective disorders and in ten normal controls. The depressed patients were divided into two groups, severely and moderately depressed. Manic patients excreted the most cyclic AMP; the severely depressed excreted the least; and the controls and moderately depressed patients showed intermediate values. In longitudinal studies of four depressed patients treated with levodopa, marked increases in urinary cyclic AMP excretion occurred. Patients treated with lithium carbonate showed changes in cyclic AMP excretion in the direction of clinical change, ie, as depression improved, cyclic AMP excretion increased and as mania improved it diminished. Factors which may influence the excretion of urinary cyclic AMP are presented.



Author Affiliations

Bethesda, Md

From the Laboratory of Chemical Pharmacology, National Heart and Lung Institute (Drs. Paul and Cramer) and the Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health (Dr. Goodwin), Bethesda, Md. Dr. Paul is now at the Neuropsychiatric Institute, University of California at Los Angeles.


Footnotes

Accepted for publication July 8, 1970.

Reprint requests to National Institute of Mental Health, Bldg 10, Room 4S239, Bethesda, Md 20014 (Dr. Goodwin).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Adenosine 3', 5'-Monophosphate in Cerebrospinal Fluid: Effect of Drugs and Neurologic Disease
Cramer et al.
Arch Neurol 1973;29:197-199.
ABSTRACT  

The "Switch Process" in Manic-Depressive Illness: II. Relationship to Catecholamines, REM Sleep, and Drugs
Bunney et al.
Arch Gen Psychiatry 1972;27:304-309.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.